logo-loader
RNS
Pets at Home Group PLC

Pets at Home Grp - FY26 pre-close statement

RNS Number : 7165Y
Pets At Home Group Plc
31 March 2026
 

Shape Description automatically generated with medium confidence

 

 

 

FOR IMMEDIATE RELEASE, 31 MARCH 2026

 

Pets at Home Group Plc: FY26 pre-close statement

Pets at Home Group plc, the UK's leading pet care business, is pleased to provide a pre-close update in respect of the 52-week period to 26 March 2026.

•

Group underlying profit before tax (PBT) for FY26 is expected to be c£92m, in line with previous guidance.

•

Our 'Retail Turnaround Plan' is progressing and is on track across our 4 priority areas, Product, Price, Execution and Cost. We have implemented our price investments and completed our £20m Group overhead savings, and while the benefits of many initiatives still lie ahead of us, we are encouraged by the progress made. In H2, our Retail business has seen volume growth, and we delivered positive LFL sales growth, as guided, with Q4 improving sequentially over Q3. Retail will deliver underlying PBT of c£30m in FY26.

•

In line with our guidance, Vet Group will deliver PBT of c£83m, a further year of strong profit progress despite the expected slowdown in sales growth as our customer cohorts reach a typical lull in activity. Vet Group performance remains underpinned by growth in average transaction values alongside growth in Care Plan revenues and plans.

•

Non-underlying costs of c£7m have been incurred in the year, in line with previous guidance.

•

We expect to finish FY26 in a net debt position of c£20m, after having returned c£85m to shareholders via dividends and buybacks during the year.

•

Following extensive consultation with our investors, we are rebalancing the way we return cash to shareholders. We will not change the total amount we return to shareholders but we will rebase our dividend to a 50% payout ratio, with that cash 'saving' returned to shareholders via our buyback programme.

•

We welcome the Final Decision Report of the CMA's veterinary services market investigation. We continue to expect no adverse impact on the growth strategy or ambitions for our Vet Group from the outcome.

•

Looking ahead to FY27, at this stage, we have c80% of our energy and FX requirements hedged and are comfortable with current analyst consensus expectations for Group underlying PBT1.

Our next scheduled update will be our FY26 preliminary results announcement on 27 May 2026.

 

1.     Current analyst consensus for FY27 Group underlying PBT is £99m with a range of £90m - £108m.

 

Investor Relations Enquiries

Pets at Home Group Plc:                                                         

Andrew Porteous, Director of Investor Relations             +44 (0) 7740 361 849

Aaron Wood, Head of Investor Relations                        +44 (0) 7702 083 154

Media Enquiries

Pets at Home Group Plc:                                                         

Natalie Cullington, Head of Communications                   +44 (0) 7974 594 701

Citigate Dewe Rogerson:                                                                     

Jos Bieneman                                                                   +44 (0) 7834 336 650                                                   

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with over 450 veterinary general practices located both in our pet care centres and in standalone locations. For more information visit: http://petsathomeplc.com/

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result, you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation ("MAR")). Upon the publication of this announcement, such information will no longer constitute inside information. Andrew Porteous, the Company's Director of Investor Relations, is the person responsible for making the notification for the purposes of Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTJMMMTMTAJTPF
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

5 min read